Wuhan Bowu Biotechnology

Wuhan Bowu Biotechnology is a clinical-stage biotechnology company based in Wuhan, China, specializing in the research, development, and manufacturing of innovative vaccines. The company focuses on high-value vaccine products, including multi-valent HPV vaccines and next-generation pneumococcal conjugate vaccines. Wuhan Bowu leverages its proprietary virus-like particle (VLP) and polysaccharide-protein conjugation platforms to address global public health challenges. Its pipeline includes candidates for tuberculosis, COVID-19, and various infectious diseases, often developed through international collaborations with organizations like PATH and GeoVax. The company aims to provide affordable and effective immunization solutions for both the Chinese and global markets. Wuhan Bowu operates within the Wuhan National Bio-industry Base, maintaining a strong emphasis on R&D and international quality standards.